Mirae Asset Global Investments Co., Ltd. Relay Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 6,623 shares of RLAY stock, worth $43,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,623
Previous 5,520
19.98%
Holding current value
$43,115
Previous $14,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RLAY
# of Institutions
213Shares Held
173MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$182 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$87.5 Million0.1% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$86.9 Million4.31% of portfolio
-
Casdin Capital, LLC New York, NY11.4MShares$74.2 Million5.53% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.6 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $783M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...